返回
Innovent Biologics, Inc.（1801.HK）价格
1801.HK 股价走势图
INNOVENT BIO (1801.HK)
Innovent Biologics, Inc.
HK$82.55
-1.13%
$-0.95
盘中： Jan 21, 10:56:43 HKT
关键数据
前收盘价
$83.2
开盘价
$83.5
当日区间
$82.3 - $83.75
52周范围
$30.75 - $109.1
交易量
2.9M
平均成交量
14.1M
每股收益（TTM）
0.74
股息收益率
--
市值
$142.0B
什么是 INNOVENT BIO？
Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 6,190 full-time employees. The company went IPO on 2018-10-31. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The firm mainly conducts its businesses within domestic and overseas markets.